Yousif Capital Management LLC Decreases Stake in CVS Health Corporation $CVS

Yousif Capital Management LLC lowered its position in CVS Health Corporation (NYSE:CVS) by 2.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 226,123 shares of the pharmacy operator’s stock after selling 5,711 shares during the period. Yousif Capital Management LLC’s holdings in CVS Health were worth $15,598,000 as of its most recent filing with the SEC.

Other large investors also recently added to or reduced their stakes in the company. Bell Investment Advisors Inc increased its holdings in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares during the last quarter. Roxbury Financial LLC increased its holdings in CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares during the last quarter. ORG Partners LLC increased its holdings in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the last quarter. Saudi Central Bank purchased a new stake in CVS Health in the 1st quarter worth about $34,000. Finally, Livelsberger Financial Advisory purchased a new stake in CVS Health in the 2nd quarter worth about $35,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Bernstein Bank reduced their target price on CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a report on Wednesday, July 16th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a report on Saturday, September 27th. Mizuho lifted their target price on CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a report on Thursday. Robert W. Baird raised CVS Health from a “neutral” rating to an “outperform” rating and lifted their target price for the company from $71.00 to $82.00 in a report on Thursday, August 14th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and set a $78.00 target price on shares of CVS Health in a report on Tuesday, August 26th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $79.80.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.22% of the stock is owned by insiders.

CVS Health Stock Up 1.5%

Shares of NYSE CVS opened at $77.89 on Monday. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $79.20. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $98.79 billion, a price-to-earnings ratio of 21.76, a PEG ratio of 0.86 and a beta of 0.60. The business has a 50-day moving average of $72.28 and a 200-day moving average of $67.67.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping the consensus estimate of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter in the previous year, the firm earned $1.83 earnings per share. CVS Health’s revenue was up 8.4% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s payout ratio is presently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.